Skin-restricted lupus erythematosus (SRL) comprises discoid lupus erythematosus (DLE), lupus tumidus (LT), and subacute cutaneous lupus erythematosus (SCLE). We and others reported a high prevalence of psychiatric disorders (PD), often undertreated, in patients with SRL.1,2 However, the impact of PDs and psychotropic medications on skin disease outcome has not been described. Thus, we decided to investigate this relationship in a patient cohort over 2.5 years.
Jalenques I, Rondepierre F, Massoubre C, et al. Treatment of Psychiatric Disorders and Skin-Restricted Lupus RemissionA Longitudinal Study. JAMA Dermatol. 2017;153(12):1331–1332. doi:10.1001/jamadermatol.2017.3590
Customize your JAMA Network experience by selecting one or more topics from the list below.